BiomX (PHGE) Total Current Liabilities (2018 - 2026)
BiomX (PHGE) posted Total Current Liabilities of $2.4 million for Q1 2026, down 61.64% sequentially from $6.4 million in Q4 2025, and down 65.15% YoY from $7.0 million in Q1 2025.
BiomX (PHGE) Total Current Liabilities (2018 - 2026) Analysis & Trends
BiomX has reported Total Current Liabilities for 9 years, with the latest figure at $2.4 million in Q1 2026.
- Quarterly Total Current Liabilities fell 65.15% year-over-year to $2.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.4 million (down 65.15% YoY) and the FY2025 annual result came in at $6.4 million, down 22.84% from the prior year.
- Total Current Liabilities declined to $2.4 million in Q1 2026 per PHGE's latest filing, from $6.4 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $12.8 million in Q3 2023 and troughed at $2.4 million in Q1 2026.
- A 5-year average of $8.1 million and a median of $7.7 million in 2022 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2023 and 2026: Total Current Liabilities jumped 79.77% in 2023, then tumbled 65.15% in 2026.
- Over 5 years, Total Current Liabilities stood at $7.9 million in 2022, then jumped by 40.77% to $11.2 million in 2023, then declined by 26.03% to $8.3 million in 2024, then dropped by 22.84% to $6.4 million in 2025, then slumped by 61.64% to $2.4 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $2.4 million, $6.4 million, and $5.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 2.53 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.51 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 438.74 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 630.93 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 2.49 Bn |
| 10 | BiomX | 361,408.40 | -806,591.60 | - | 2.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.45 Mn |
| Dec 31, 2025 | 6.38 Mn |
| Sep 30, 2025 | 5.23 Mn |
| Jun 30, 2025 | 6.26 Mn |
| Mar 31, 2025 | 7.02 Mn |
| Dec 31, 2024 | 8.27 Mn |
| Sep 30, 2024 | 8.94 Mn |
| Jun 30, 2024 | 7.31 Mn |
| Dec 31, 2023 | 11.18 Mn |
| Sep 30, 2023 | 12.78 Mn |
| Jun 30, 2023 | 11.67 Mn |
| Mar 31, 2023 | 10.20 Mn |
| Dec 31, 2022 | 7.94 Mn |
| Sep 30, 2022 | 7.48 Mn |
| Jun 30, 2022 | 6.49 Mn |
| Mar 31, 2022 | 9.85 Mn |
| Dec 31, 2021 | 11.04 Mn |
| Sep 30, 2021 | 9.00 Mn |
| Jun 30, 2021 | 7.76 Mn |
| Mar 31, 2021 | 7.80 Mn |